Condensed Consolidated Statement of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Beginning Balance at Dec. 31, 2022	$ 550,932	$ 62	$ 895,801	$ (694)	$ (344,237)
Beginning Balance (in shares) at Dec. 31, 2022		61,730,816
Exercise of stock options	116		116
Exercise of stock options (in shares)		29,010
Unrealized loss on available-for-sale securities	457			457
Stock-based compensation	8,024		8,024
Issuance of common stock from At-the-Market offering, net of issuance costs, shares		103,184
Issuance of common stock from At-the-Market offering, net of issuance costs	1,922		1,922
Net Income (Loss)	(51,975)				(51,975)
Ending Balance at Mar. 31, 2023	509,476	$ 62	905,863	(237)	(396,212)
Ending balance (in shares) at Mar. 31, 2023		61,863,010
Beginning Balance at Dec. 31, 2022	550,932	$ 62	895,801	(694)	(344,237)
Beginning Balance (in shares) at Dec. 31, 2022		61,730,816
Net Income (Loss)	(105,958)
Ending Balance at Jun. 30, 2023	465,222	$ 62	916,109	(754)	(450,195)
Ending balance (in shares) at Jun. 30, 2023		62,064,279
Beginning Balance at Mar. 31, 2023	509,476	$ 62	905,863	(237)	(396,212)
Beginning Balance (in shares) at Mar. 31, 2023		61,863,010
Vesting of restricted stock units (in shares)		50,537
Exercise of stock options	548		548
Exercise of stock options (in shares)		98,598
Issuance of common stock under Employee Stock Purchase Plan, shares		52,134
Issuance of common stock under Employee Stock Purchase Plan	685		685
Unrealized loss on available-for-sale securities	(517)			(517)
Stock-based compensation	9,013		9,013
Net Income (Loss)	(53,983)				(53,983)
Ending Balance at Jun. 30, 2023	465,222	$ 62	916,109	(754)	(450,195)
Ending balance (in shares) at Jun. 30, 2023		62,064,279
Beginning Balance at Dec. 31, 2023	$ 599,502	$ 82	1,143,453	272	(544,305)
Beginning Balance (in shares) at Dec. 31, 2023	81,969,693	81,969,693
Vesting of restricted stock units (in shares)		7,290
Vesting of restricted stock units	$ 0
Exercise of stock options	301		301
Exercise of stock options (in shares)		76,044
Unrealized loss on available-for-sale securities	(772)			(772)
Stock-based compensation	10,341		10,341
Issuance of common stock from At-the-Market offering, net of issuance costs, shares		1,766,835
Issuance of common stock from At-the-Market offering, net of issuance costs	22,433		22,431
Net Income (Loss)	(48,736)				(48,736)
Ending Balance at Mar. 31, 2024	583,069	$ 84	1,176,526	(500)	(593,041)
Ending balance (in shares) at Mar. 31, 2024		83,819,862
Beginning Balance at Dec. 31, 2023	$ 599,502	$ 82	1,143,453	272	(544,305)
Beginning Balance (in shares) at Dec. 31, 2023	81,969,693	81,969,693
Exercise of stock options (in shares)	597,039
Net Income (Loss)	$ (98,541)
Ending Balance at Jun. 30, 2024	$ 546,094	$ 85	1,189,470	(615)	(642,846)
Ending balance (in shares) at Jun. 30, 2024	84,552,269	84,552,269
Beginning Balance at Mar. 31, 2024	$ 583,069	$ 84	1,176,526	(500)	(593,041)
Beginning Balance (in shares) at Mar. 31, 2024		83,819,862
Vesting of restricted stock units (in shares)		104,426
Exercise of stock options	826	$ 1	825
Exercise of stock options (in shares)		520,995
Issuance of common stock under Employee Stock Purchase Plan, shares		106,986
Issuance of common stock under Employee Stock Purchase Plan	472		472
Unrealized loss on available-for-sale securities	(115)			(115)
Stock-based compensation	11,647		11,647
Net Income (Loss)	(49,805)				(49,805)
Ending Balance at Jun. 30, 2024	$ 546,094	$ 85	$ 1,189,470	$ (615)	$ (642,846)
Ending balance (in shares) at Jun. 30, 2024	84,552,269	84,552,269